Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Capecitabine in Metastatic Colorectal Cancer
NCT00159445Phase 2Completed
- Sponsor
- University of Southern California
- Start
- Mar 2004
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine in metastatic colorectal cancer (mCRC), sponsored by University of Southern California. Primary endpoint: Time to Progression. Started Mar 2004; status: completed.
02
Drugs
gemcitabine
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00159445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159445.